ClinicalTrials.Veeva

Menu

Contemporary Characteristics of Penile Cancer

M.D. Anderson Cancer Center logo

M.D. Anderson Cancer Center

Status

Enrolling

Conditions

Squamous Cell Carcinoma of the Penis
Penile Carcinoma

Treatments

Other: Data Capture
Other: Questionnaire Administration

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT04996849
NCI-2021-07693 (Registry Identifier)
PCR04-0148 (Other Identifier)

Details and patient eligibility

About

This study develops a prospective database of patients who are evaluated and treated for penile cancer. This will facilitate analyzing trends in cancer incidence, risk factors, treatment, complications, and tumor progression. It will also prospectively validate the importance of pathological prognostic factors previously reported and outcome related to contemporary treatment.

Full description

PRIMARY OBJECTIVE:

I. To prospectively collect data on the presenting features, management and outcome of penile carcinoma at M.D. Anderson Cancer Center, and Harris Health System and Katy, Sugar Land, The Woodlands and Bay Area Regional Care Centers.

OUTLINE:

Patients undergo data collection every 6 months for up to 15 years.

Enrollment

1,000 estimated patients

Sex

Male

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All diagnosed patients with a primary penile malignancy, including those with squamous carcinoma

Exclusion criteria

  • No patient meeting the above criteria will be excluded

Trial design

1,000 participants in 1 patient group

Observational (data collection)
Description:
Patients undergo data collection every 6 months for up to 15 years.
Treatment:
Other: Questionnaire Administration
Other: Data Capture

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems